ZA200906226B - Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents - Google Patents

Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents

Info

Publication number
ZA200906226B
ZA200906226B ZA200906226A ZA200906226A ZA200906226B ZA 200906226 B ZA200906226 B ZA 200906226B ZA 200906226 A ZA200906226 A ZA 200906226A ZA 200906226 A ZA200906226 A ZA 200906226A ZA 200906226 B ZA200906226 B ZA 200906226B
Authority
ZA
South Africa
Prior art keywords
glucocorticoids
inflammatory
fatty acid
acid esters
cancer agents
Prior art date
Application number
ZA200906226A
Other languages
English (en)
Inventor
Finn Myhren
Marit Liland Sandvold
Ole Hendrik Eriksen
Steinar Hagen
Original Assignee
Clavis Pharma Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clavis Pharma Asa filed Critical Clavis Pharma Asa
Publication of ZA200906226B publication Critical patent/ZA200906226B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200906226A 2007-03-20 2009-09-08 Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents ZA200906226B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20071485A NO331891B1 (no) 2007-03-20 2007-03-20 Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS

Publications (1)

Publication Number Publication Date
ZA200906226B true ZA200906226B (en) 2010-05-26

Family

ID=39734182

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200906226A ZA200906226B (en) 2007-03-20 2009-09-08 Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents

Country Status (16)

Country Link
US (1) US9428540B2 (no)
EP (1) EP2121723A2 (no)
JP (2) JP2010522233A (no)
KR (1) KR20090123961A (no)
CN (1) CN101687904A (no)
AU (1) AU2008227246B2 (no)
CA (1) CA2680155A1 (no)
IL (1) IL200655A0 (no)
MX (1) MX2009009838A (no)
NO (1) NO331891B1 (no)
NZ (1) NZ579382A (no)
RU (1) RU2462472C2 (no)
TW (1) TWI428133B (no)
UA (1) UA96794C2 (no)
WO (1) WO2008115069A2 (no)
ZA (1) ZA200906226B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497292B2 (en) 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
NO331891B1 (no) 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
GB201006181D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
PT105723B (pt) * 2011-05-26 2014-03-24 Hovione Farmaci Ncia S A Método para a preparação de compostos orgânicos biologicamente activos
US9155747B2 (en) * 2012-09-13 2015-10-13 Chiesi Farmaceutici S.P.A. Isoxazolidine derivatives
AU2017274442B2 (en) 2016-06-02 2021-08-19 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
JPWO2018159808A1 (ja) * 2017-03-03 2019-12-26 国立研究開発法人国立がん研究センター 抗ｉｌ−７ｒ抗体の抗体薬物コンジュゲートと、がんまたは炎症を処置することに用いるための、抗ｉｌ−７ｒ抗体と細胞傷害剤との抗体薬物コンジュゲートを含む医薬組成物
CN108659090A (zh) * 2017-03-31 2018-10-16 天津药业研究院有限公司 一种17β-硫代羧酸氯甲酯类甾体化合物的制备方法
EP3884962A1 (en) 2017-12-01 2021-09-29 AbbVie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1227992A (no) * 1968-01-23 1971-04-15 Koninklijke Gist Spiritus
IT1043956B (it) * 1970-10-17 1980-02-29 Isf Spa 21 esteri di acidi grassi insaturi del desa e beta metazone
JPS56138200A (en) * 1980-02-15 1981-10-28 Glaxo Group Ltd Androstane carbothioate compound
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
JPH0381286A (ja) * 1989-08-22 1991-04-05 Green Cross Corp:The ステロイド外用剤
JPH05132498A (ja) * 1991-11-08 1993-05-28 Asahi Glass Co Ltd ステロイド誘導体およびその製剤
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
AU2001242879A1 (en) 2000-03-24 2001-10-03 Dsm N.V. Radiation-curable coatings suitable for high-speed application onto optical fibers
GB0017988D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Novel process
GB0202563D0 (en) * 2002-02-04 2002-03-20 Glaxo Group Ltd Process
US20040235811A1 (en) * 2002-10-08 2004-11-25 Sepracor Inc. Fatty acid modified forms of glucocorticoids
NO331891B1 (no) 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS

Also Published As

Publication number Publication date
MX2009009838A (es) 2010-01-15
WO2008115069A3 (en) 2008-11-13
RU2462472C2 (ru) 2012-09-27
JP2010522233A (ja) 2010-07-01
AU2008227246A1 (en) 2008-09-25
TWI428133B (zh) 2014-03-01
KR20090123961A (ko) 2009-12-02
JP2014012657A (ja) 2014-01-23
WO2008115069A2 (en) 2008-09-25
NO331891B1 (no) 2012-04-30
US20100099654A1 (en) 2010-04-22
NZ579382A (en) 2011-09-30
US9428540B2 (en) 2016-08-30
AU2008227246B2 (en) 2012-06-14
EP2121723A2 (en) 2009-11-25
UA96794C2 (ru) 2011-12-12
NO20071485L (no) 2008-09-22
RU2009138488A (ru) 2011-04-27
TW200846010A (en) 2008-12-01
CN101687904A (zh) 2010-03-31
IL200655A0 (en) 2010-05-17
CA2680155A1 (en) 2008-09-25

Similar Documents

Publication Publication Date Title
ZA200906226B (en) Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents
EP2433630A4 (en) SELF-EMULSIFIABLE COMPOSITION OF FATTY ACID 3
EP2459189A4 (en) FATTY ACIDS AS ANTI-INFLAMMATORY ACTIVE SUBSTANCES
EP2173699A4 (en) PRODUCTION AND PURIFICATION OF POLYUNSATURATED FATTY ACID ESTERS
EP2658837A4 (en) Glycerides and fatty acid mixtures and methods of using same
EP2498602A4 (en) STABILIZED FORMULATIONS FROM FATTY ACIDS
EP2451907A4 (en) SYNTHESIS OF BIOFUEL ESTERS FROM DERIVATIVE UNSATURATED FATTY ACIDS
GB0915693D0 (en) Fatty acid formulations and methods of use thereof
SI3159329T1 (sl) Uporaba 2-hidroksi derivatov polinenasičenih maščobnih kislin kot zdravila
GB2464886B (en) Preparation of fatty acids in solid form
IL218460A0 (en) Omega-3 fatty acid enriched shortenings and nut butters
HK1155733A1 (en) Processes for the preparation of 4-oxo-octahydro-indole-1-carbocylic acid methyl ester and derivatives thereof 4----1-
IL213354A (en) Alpha-monoclonal fatty acid alpha history for use as a drug
ZA201004144B (en) Fatty acid by-products and methods of using same
AP2831A (en) Production of fatty acid and fatty acid ester
HK1146733A1 (en) Production of fatty acid and fatty acid ester
PL393249A1 (pl) Mieszanina nowych estrów sprzężonych kwasów linolowych z betuliną i sposób jej otrzymywania
MY157821A (en) Synthesis of ascorbyl fatty acid ester
GB0801878D0 (en) Process for the conversion of fatty acids and derivatives thereof
GB0810779D0 (en) Process for the conversion of fatty acids and derivatives thereof